跳至主要内容
临床试验/NCT03057756
NCT03057756已完成不适用

Nine Months' Short Course Regimen Protocol for the Treatment of Multidrug Resistance-tuberculosis (MDR-TB) Patients in Gabon

Centre de Recherche Médicale de Lambaréné1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2015年9月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
1
主要终点
cure rate post treatment

研究概览

简要总结

The principal objective is to evaluate a cure rate and number of adverse events of with confirmed multidrug-resistant tuberculosis patient treated with a 9months regimen.

详细描述

Study participants will be followed up, under existing protocol derived from a study protocol developed by the "Union internationale contre les maladies respiratoires" and carried out already in 9 Africans countries. Participants will be hospitalised for at least four month, period which they will be given treatments, assessed for adverse events, monitored for TB-MR strains using culture techniques, at the monthly basis. If patients found with negative sputum culture at month four they will be dischrged from the hospital, and then treated four an additional five montns and then follow up, clinically and biologically for an additional six months before being declared as cured.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 15 years and above
  • Never been treated with second line anti-TB drugs for more than one month,
  • Give written consent to participate
  • Agree to be hospitalised for at least four months in specialised healthcare
  • Willing to adhere to ambulatory directly observed treatment by a healthcare worker;

排除标准

  • Pregnant during inclusion process
  • Presented with altered clinical status condition as judged by the clinician
  • Knowing of history of hypersensitivity reaction to any of the drugs to be used
  • Baseline ECG does not show a QT space superior to 500ms
  • Refusal to participate into study.

研究组 & 干预措施

TB-MR patients

Patients older than 15 years old receiving Km+ Mfx+ Pto + H + Cfz +E+Z

干预措施: Km+ Mfx+ Pto + H + Cfz +E+Z (Combination Product)

结局指标

主要结局

cure rate post treatment

时间窗: Six months post treatment

Proportion of participants alive and presented with negative sputum culture for TB and with the absence of clinical, X-Ray and biological disorders related to TB

次要结局

  • TB-culture(4 months after start of the treatment)
  • Regimen tolorability(Throughout treatment period (9months))
  • Adverse events(duration of participant in the study (15months))

研究者

发起方
Centre de Recherche Médicale de Lambaréné
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Ayola Akim ADEGNIKA

Professor

Centre de Recherche Médicale de Lambaréné

研究点 (1)

Loading locations...

相似试验